Cite
Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy.
MLA
Liu, Qianqian, et al. “Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy.” Advanced Functional Materials, vol. 34, no. 13, Mar. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1002/adfm.202311677.
APA
Liu, Q., Chen, X., Jiang, Y., Yan, M., Yu, B., Zhang, W., Cen, Y., Zhang, J., Zhang, J., Lei, Q., Li, S., & Yang, B. (2024). Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy. Advanced Functional Materials, 34(13), 1–12. https://doi.org/10.1002/adfm.202311677
Chicago
Liu, Qianqian, Xiayun Chen, Yong Jiang, Mengyi Yan, Baixue Yu, Wei Zhang, Yi Cen, et al. 2024. “Self‐Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy.” Advanced Functional Materials 34 (13): 1–12. doi:10.1002/adfm.202311677.